Up‐regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy

Using new castration‐resistant prostate cancer (CRPC) cell lines developed from LNCaP cells as a model for CRPC, we searched for novel biomarkers by analyzing the proteins secreted in culture supernatants. The results showed that the levels of secretory leukocyte protease inhibitor (SLPI) in these c...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Yu, Goto, Takayuki, Li, Xin, Nakayama, Kenji, Okasho, Kosuke, Takeda, Masashi, Mizuno, Kei, Kimura, Hiroko, Uegaki, Masayuki, Sumiyoshi, Takayuki, Teramoto, Yuki, Akamatsu, Shusuke, Kobayashi, Takashi, Ogawa, Osamu, Inoue, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939162/
https://www.ncbi.nlm.nih.gov/pubmed/36812122
http://dx.doi.org/10.1002/cam4.5134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939162/
https://www.ncbi.nlm.nih.gov/pubmed/36812122
http://dx.doi.org/10.1002/cam4.5134

Ejemplares similares